Mustang Bio completes venture financing

Cancer play Mustang Bio Inc. (New York, N.Y.), a subsidiary of Fortress Biotech Inc. (NASDAQ:FBIO, New York, N.Y.), raised $94.5 million in a private placement on Feb. 2. OPN Capital Markets was the...